Bux Pain Management Incorporates Advanced SynchroMed III Pain Pump into Treatment Options

Bux Pain Management ● Photo Credit: Bux Pain Management

LEXINGTON, Ky., April 3, 2024 (VSNewsNetwork.com) - Bux Pain Management has announced the integration of the SynchroMed III intrathecal drug delivery system into its array of treatment options for patients suffering from chronic pain, cancer pain, and severe spasticity. This system, which was approved by the FDA on October 10, 2023, is designed to deliver medication directly to the spinal fluid, aiming to provide a more effective solution for pain management.

Dr. Anjum Bux, a pain management specialist with 18 years of experience and a history of approximately 500 intrathecal pain pump implants, was one of the first in the United States to utilize this new technology. The first Kentucky patient to receive the SynchroMed III pump under Dr. Bux's care has reported significant improvements in their ability to perform daily activities and engage with family.

"The SynchroMed III pump represents a monumental leap forward in our ability to manage chronic pain for patients," Dr. Bux commented. "By delivering medication directly to the pain's source, we can significantly improve the quality of life for our patients with minimal side effects."

The SynchroMed III system, developed by Medtronic, features advancements such as a "refill only" workflow and the capability for post-implantation firmware updates, which contribute to its safety, efficiency, and effectiveness. It also allows for compatibility with 1.5T and 3T full-body MRI scans, facilitating comprehensive diagnostic imaging for patients undergoing treatment.

This introduction is particularly significant in the context of the opioid crisis, offering a potentially safer and more effective alternative for pain management. Dr. Bux has already successfully implanted 20 SynchroMed III pumps and manages around 700 pain pumps, underscoring his commitment to providing advanced care for those dealing with chronic neck or low back pain.

For more information about the SynchroMed III system and other services offered by Bux Pain Management, interested individuals are encouraged to visit www.buxpainmanagement.com.

Source: Bux Pain Management via Newswire

Previous
Previous

Dan Gertsacov Appointed CEO of Big Green Egg

Next
Next

NEXTAFF North Country Marks Six Months of Service in Healthcare Staffing